Rapid melting curve analysis for genetic variants that underlie inter-individual variability in stable warfarin dosing (Q59689754)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661181%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

Rapid melting curve analysis for genetic variants that underlie inter-individual variability in stable warfarin dosing (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661181%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661181%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

John F Carlquist

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661181%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Jason T McKinney

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661181%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Zachary P Nicholas

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661181%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Jessica L Clark

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661181%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Samera F Kahn

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661181%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Benjamin D Horne

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661181%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Joseph B Muhlestein

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661181%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Jeffrey L Anderson

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661181%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

29 July 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661181%20AND%20SRC:MED&resulttype=core&format=json

Journal of Thrombosis and Thrombolysis

2 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661181%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661181%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661181%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

1-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661181%20AND%20SRC:MED&resulttype=core&format=json

Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study.

2 January 2020

cites work

1 reference

12 December 2020

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

1 reference

12 December 2020

Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9

1 reference

12 December 2020

Analysis of risk factors for over-anticoagulation in patients receiving long-term warfarin

1 reference

12 December 2020

Validation of methods for CYP2C9 genotyping: frequencies of mutant alleles in a Swedish population.

1 reference

12 December 2020

A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity.

1 reference

12 December 2020

A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin.

1 reference

12 December 2020

Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy.

1 reference

12 December 2020

Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group

1 reference

12 December 2020

Cardiovascular pharmacogenomics: current status, future prospects

1 reference

12 December 2020

The negative impact of biological variation in the effect and clearance of warfarin on methods for prediction of dose requirements

1 reference

12 December 2020

Genotyping and phenotyping the cytochrome p-450 enzymes

1 reference

12 December 2020

CYP2C9 Ile359 and Leu359 variants: enzyme kinetic study with seven substrates

1 reference

12 December 2020

Development of a Contemporary Bleeding Risk Model for Elderly Warfarin Recipients

1 reference

12 December 2020

High-resolution genotyping by amplicon melting analysis using LCGreen

1 reference

12 December 2020

The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen

1 reference

12 December 2020

The R144C change in the CYP2C9*2 allele alters interaction of the cytochrome P450 with NADPH:cytochrome P450 oxidoreductase

1 reference

12 December 2020

Genetic analysis of the human cytochrome P450 CYP2C9 locus

1 reference

12 December 2020

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose

1 reference

12 December 2020

Identification of the gene for vitamin K epoxide reductase

1 reference

12 December 2020

10.1007/S11239-007-0077-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661181%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference